Scientific article
Review
English

Treatment strategies for acute pulmonary embolism

Published in

Expert opinion on pharmacotherapy, vol. 10, no. 7, p. 1159-1171

Publication date

2009

Abstract

BACKGROUND: Acute pulmonary embolism (PE) is a life-threatening condition that has been treated with anticoagulation for almost 50 years. OBJECTIVES: To review the current treatment options for PE and discuss recently published new features. METHODS: We reviewed literature involving the treatment strategies for venous thromboembolism (VTE) and in particular pulmonary embolism. Specific attention was drawn towards the evidence of the present treatment and of drugs being studied in Phase III trials. RESULTS/CONCLUSIONS: Treatment of acute PE consists of parenteral administration of heparin, low-molecular-weight heparin or fondaparinux overlapped and followed by oral vitamin K antagonists for a minimum of 3 months. Contemporary features include the emergence of new anticoagulant drugs such as oral synthetic inhibitors of thrombin or factor Xa. The duration of anticoagulation for unprovoked VTE remains highly debated.

Keywords

  • Acute Disease
  • Embolectomy
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular/drug therapy/surgery/therapy
  • Pulmonary Embolism/complications/drug therapy/surgery/therapy
  • Thrombolytic Therapy
  • Vena Cava Filters

Citation (ISO format)

BLONDON, Marc, BOUNAMEAUX, Henri, RIGHINI, Marc Philip. Treatment strategies for acute pulmonary embolism. In: Expert opinion on pharmacotherapy, 2009, vol. 10, n° 7, p. 1159–1171. doi: 10.1517/14656560902911470

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1465-6566
626views
0downloads

Technical informations

Creation

23/04/2012 13:22:56

First validation

23/04/2012 13:22:56

Update

16/02/2026 08:38:45

Status update

16/02/2026 08:38:45

Last indexation

16/02/2026 08:38:47
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated